- Regeneron Pharmaceuticals (NASDAQ:REGN): Q2 EPS of $1.73.
- Revenue of $457.64M misses by $12.99M.
Regeneron Pharma EPS of $1.73, misses on revenue
Recommended For You
More Trending News
About REGN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| REGN | - | - |
| Regeneron Pharmaceuticals, Inc. | ||